tradingkey.logo

Blueprint Medicines hits record high on Sanofi's $9 bln buyout offer

ReutersJun 2, 2025 2:33 PM

Blueprint Medicines BPMC.O jumps 26.5% to record high of $128.15

*Stock set for its best day on record, if gains hold

French drugmaker Sanofi SASY.PA to buy Blueprint for more than $9 billion

Sanofi paying $129/share in cash for Blueprint, a 27% premium to last close

*Brokerage Leerink Partners says the deal is "positive for the sector"

Brokerage Guggenheim says it viewed BPMC as one of its "top strategic M&A ideas of 2025"

Deal's equity value ~$9.1 billion, with potential to increase to $9.5 billion, including contingent value rights

Acquisition expected to be finalized in Q3 2025

BPMC up 16.2% this year, as of last close

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI